Top Pharmaceuticals Firms in Massachusetts: An Exploration
Top Pharmaceuticals Firms in Massachusetts: An Exploration
The pharmaceutical industry in Massachusetts is a burgeoning field that boasts an eclectic mix of companies dedicated to improving human health. These entities range from corporations steeped in rigorous scientific research like Biogen, to innovative drug discovery startups like Relay Therapeutics. Their objectives encompass a vast array of disease areas, including neurological disorders, blood diseases, and genetic conditions. These Massachusetts-based pharmaceutical companies are redefining the boundaries of patient care and therapeutics through their relentless pursuit of innovation, dedication to health equity, and commitment towards a healthier global community. The future of this industry seems promising, potentially heralding an era of new therapeutics and unprecedented patient benefit.
Top 22 pharmaceuticals companies in Massachusetts
1. Biogen
- Website: biogen.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 1978
- Headcount: 5001-10000
Biogen is a science-driven company that aims to transform patient lives by solving societal problems. They focus on diseases like Amyotrophic Lateral Sclerosis, Alzheimer's Disease, and Multiple Sclerosis. Biogen offers a portfolio of medicines, including biosimilars, and is committed to diversity, equity, and inclusion. They have a strong R&D expertise and collaborate with partners for innovation. Biogen emphasizes access and health equity while prioritizing a healthy climate and global community.
2. Takeda Oncology
- Website: takedaoncology.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 1993
- Headcount: 1001-5000
Takeda Oncology is a pharmaceutical company dedicated to discovering and developing innovative therapies for the treatment of hematologic cancers and other blood diseases. They focus on breaking down barriers preventing the use of NGS and empowering patients through patient-centric partnerships. Their pipeline includes transformative treatments and they have a strong presence in the oncology field.
3. Relay Therapeutics
- Website: relaytx.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2016
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
Relay Therapeutics is a drug discovery company that is revolutionizing the traditional approach by visualizing protein motion in HD movies. They are focused on bringing life-changing medicines to patients, with a pipeline of therapeutic candidates targeting precision oncology and genetic disease.
4. Replimune
- Website: replimune.com
- Headquarters: Woburn, Massachusetts, United States
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
Replimune is a company that offers innovative solutions in the field of biotechnology. They specialize in developing oncolytic immunotherapies for the treatment of cancer. Replimune's cutting-edge technology enables targeted delivery of therapeutic agents to improve patient outcomes.
5. Laronde
- Website: laronde.bio
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2017
- Headcount: 11-50
- Latest funding type: Series B
Laronde is a company that specializes in the development and production of endless RNA (eRNA™), a new class of programmable medicines. With the potential to revolutionize the field of drug modality, eRNA offers therapeutic proteins that can be expressed inside the body by using non-coding regions to control expression, stability, targeting, and more.
6. Arrakis Therapeutics
- Website: arrakistx.com
- Headquarters: Waltham, Massachusetts, United States
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Series B
Arrakis is a company focused on pioneering RNA-targeted small molecule therapeutics. They are dedicated to the development and discovery of innovative medicines that can degrade RNA molecules. With a mission to explore and improve RNA-based treatments, Arrakis aims to make significant contributions in the field of molecular therapeutics.
7. Targanta Therapeutics
- Website: targanta.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2005
- Headcount: 51-200
- Latest funding type: Acquired
Targanta is a pharmaceutical company specializing in the discovery and development of antibacterial agents. They offer a drug discovery platform that focuses on targeting gram-positive pathogens, particularly Staphylococcus aureus. With a broad potential against these pathogens, Targanta aims to provide new solutions for the treatment of infectious diseases.
8. FogPharma
- Website: fogpharma.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2016
- Headcount: 51-200
- Latest funding type: Series D
FogPharma is a fast-growing company specializing in the development of innovative precision medicines. Their first-in-class programs target elusive drivers of cancer, utilizing their Helicon polypeptides that combine the strength and specificity of antibodies with the benefits of small molecules. With a focus on achieving universal druggability, FogPharma is pioneering a new class of drugs to address the limitations of current precision medicines.
9. X-Chem, Inc.
- Website: x-chemrx.com
- Headquarters: Waltham, Massachusetts, United States
- Founded: 2010
- Headcount: 51-200
- Latest funding type: Acquired
X-Chem is a leader in small molecule drug discovery and DNA-encoded library (DEL) technology. They combine DEL and medicinal chemistry expertise with groundbreaking AI solutions to accelerate the discovery of new drugs. Their services include DEL screening, custom synthesis, and medicinal chemistry. X-Chem's proprietary ArtemisAI technology revolutionizes the discovery of new medicines by utilizing machine learning models and extensive DEL data.
10. Foghorn Therapeutics Inc.
- Website: foghorntx.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2016
- Headcount: 51-200
- Latest funding type: Ipo
Foghorn Therapeutics is a pioneering biotech company that leverages unique insights into the chromatin regulatory system to develop a new class of precision therapeutic candidates. Their therapies correct abnormal gene expression, targeting disease dependencies and offering potential breakthroughs in treating cancer and other serious diseases.
11. Jnana Therapeutics
- Website: jnanatx.com
- Headquarters: Boston, Massachusetts, United States
- Founded: 2017
- Headcount: 51-200
- Latest funding type: Series C
Jnana Therapeutics is a biotech company focused on developing innovative therapies for the treatment of diseases. They specialize in RAPID platform-based drug discovery and have recently received FDA clearance for their IND application for JNT-517, a potential treatment for Phenylketonuria.
12. Cullinan Oncology
- Website: cullinanoncology.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2017
- Headcount: 11-50
- Latest funding type: Post Ipo Equity
Cullinan Oncology is a company focused on targeted oncology research and development programs. They work towards innovating new therapies and treatments for patients with cancer.
13. Invicro
- Website: invicro.com
- Headquarters: Needham, Massachusetts, United States
- Founded: 2008
- Headcount: 201-500
- Latest funding type: Acquired
Invicro is a company that specializes in medical imaging capabilities and expertise across various therapeutic areas. They offer solutions for drug development problems through data analysis, capture, design, and management.
14. Generate Biomedicines
- Website: generatebiomedicines.com
- Headquarters: Somerville, Massachusetts, United States
- Founded: 2018
- Headcount: 201-500
- Latest funding type: Series B
Generate Biomedicines is a therapeutics company utilizing machine learning, biological engineering, and medicine to develop breakthrough medicines.
15. Valo
- Website: valohealth.com
- Headquarters: Boston, Massachusetts, United States
- Founded: 2019
- Headcount: 51-200
- Latest funding type: Series C
Valo Health is a company dedicated to advancing the discovery and development of life-changing medicines by harnessing high-quality patient data and powerful AI-driven technology. They have assembled a team of software engineers, data scientists, biologists, medicinal chemists, and big-picture thinkers to accelerate the creation of innovative drugs.
16. Cellarity
- Website: cellarity.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2017
- Headcount: 51-200
- Latest funding type: Series C
Cellarity is a company that specializes in rewriting the rules of drug creation. Their platform provides critical insights into cellular dysfunction and reveals new biology that can be used to treat various diseases. With programs in hematology, immuno-oncology, and metabolism, Cellarity is pioneering a new generation of medicines.
17. Dragonfly Therapeutics, Inc.
- Website: dragonflytx.com
- Headquarters: Waltham, Massachusetts, United States
- Founded: 2015
- Headcount: 51-200
- Latest funding type: Series Unknown
Dragonfly Therapeutics is a clinical-stage biotech company that rapidly develops drugs in collaboration with pharma partners. They focus on expanding fields such as oncology, immunology, neuromuscular disease, virology, and more.
18. Scholar Rock
- Website: scholarrock.com
- Headquarters: Cambridge, Massachusetts, United States
- Founded: 2012
- Headcount: 51-200
- Latest funding type: Post Ipo Equity
Scholar Rock is a company that takes a unique approach to fighting disease. They use their technology platform and structural insights to discover new medicines that selectively target the inactive forms of growth factors, with the aim of avoiding toxicity and improving efficacy.
19. Health Advances
- Website: healthadvances.com
- Headquarters: Newton, Massachusetts, United States
- Founded: 1992
- Headcount: 51-200
- Latest funding type: Acquired
Health Advances is a consulting firm that operates at the intersection of science, technology, and business strategy. They provide innovative solutions to clients based on deep industry insight, rigorous analysis, and an objective perspective.
20. Alloy Therapeutics, Inc.
- Website: alloytx.com
- Headquarters: Boston, Massachusetts, United States
- Founded: 2017
- Headcount: 51-200
- Latest funding type: Series D
Alloy Therapeutics is a biotechnology company based in Athens, GA. We empower drug discovery across 6 biologic modalities through our platforms, services, and company creation. We offer a spectrum of biologic discovery platforms to help research groups find the best drug against their target and develop innovative therapeutic formats.
21. Neumora
- Website: neumoratx.com
- Headquarters: Watertown, Massachusetts, United States
- Founded: 2020
- Headcount: 51-200
- Latest funding type: Series B
Neumora is a neuroscience R&D company that utilizes precision data science to redefine the development of effective medicines for brain diseases. By integrating multiple types of data, their proprietary platform creates Data Biopsy Signatures™ and Precision Phenotypes™ to map disease drivers to patient subtypes, increasing the probability of successful therapeutics.
22. ROME Therapeutics
- Website: rometx.com
- Headquarters: Boston, Massachusetts, United States
- Founded: 2020
- Headcount: 11-50
- Latest funding type: Series B
ROME Therapeutics is a pioneering company at the forefront of biology, focused on unlocking the potential of RNA for revolutionary therapeutics. With cutting-edge research and breakthrough technologies, we aim to harness the power of RNA to target and treat previously undruggable diseases.
Want to find more pharmaceuticals companies?
If you want to find more companies that offer a range of innovative therapeutics and health solutions you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.
With Inven you'll also get to know the company's:
- Ownership: Which of these are private equity backed? Which are family-owned?
- Contact data: Who are the owners and CEO's? What are their emails and phone numbers?
- Financials: How do these companies perform financially? What are their revenues and profit margins?
...and a lot more!
